Elsevier

Neuropharmacology

Volume 19, Issue 3, March 1980, Pages 259-267
Neuropharmacology

The effects of iron deficiency on brain biogenic monoamine biochemistry and function in rats

https://doi.org/10.1016/0028-3908(80)90148-3Get rights and content

Abstract

Rats were made iron-deficient by feeding them on a semi-synthetic diet containing milk powder, low in iron. Control rats were fed the same diet with an iron-supplement. When the rats were iron deficient (haemoglobin 6.9 ± 0.6 g/dl) a study was made of the iron distribution in the brain. Distribution was similar in control and iron-deficient rats with the highest concentration in the caudate nucleus, hypothalamus and cerebellum. Sub-cellular distribution studies showed the highest concentration to be in the crude mitochondrial fraction. The iron-deficient group had an approx. 60% decrease in brain iron stores.

Measurement was also made of the monoamine metabolising enzymes (MAO) in iron-deficient rats. Despite large decreases in peripheral MAO activity no decrease in central MAO activity was observed in these rats. Nor was there any decrease in brain tryptophan hydroxylase or aldehyde dehydrogenase activity. In very severe iron-deficient (haemoglobin 4.5 ± 0.6 g/dl) rats, brain MAO activity still decreased only by 15.70% while heart MAO activity decreased by over 60%, while there was still no change in tryptophan hydroxylase activity.

Iron deficient rats showed decreased behavioural responses following increased brain 5-hydroxytryptamine (5-HT) synthesis or after administration of the 5-HT agonist 5-methoxy N, N-dimethyltryptamine. They also showed decreased behavioural responses following administration of tranylcypromine plus l-DOPA, methamphetamine or apomorphine. No change in brain tryptophan or 5-HT synthesis was observed although endogenous 5-HT content was decreased. No changes were seen in brain dopamine or noradrenaline content, nor in the activity of dopamine-sensitive adenylate cyclase. Brain protein synthesis was also unaltered. Eight days after restoration of the iron plus diet the behavioural responses were normalised, but injection of ferrous gluconate (acutely) failed to restore the behaviour.

Reasons for the altered post-synaptic monoamine behavioural responses being unlikely to be the result of anaemia are discussed and the relevance of decreased monoamine function in iron-deficiency is also discussed, particularly with regard to the high incidence of this nutritional disorder.

References (57)

  • J.H. Tong et al.

    Tryptophan hydroxylase: purification and some properties of the enzyme from rabbit hindbrain

    J. biol. Chem.

    (1975)
  • M.C. Voorhess et al.

    Iron-deficiency anaemia and increased urinary norepinephrine excretion

    J. Pediat.

    (1975)
  • B.L. Brown et al.

    A simple and sensitive saturation assay method for the method of measurement of adenosine 3'5' cyclic monophosphate

    Biochem. J.

    (1971)
  • R.W. Colburn et al.

    Adenosine triphosphate-metanorepinephrine ternary complexes and catecholamine binding

    Nature, Lond.

    (1965)
  • J. Cott et al.

    Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems

    J. Neural Transm.

    (1977)
  • J.N. Cumings

    Copper and iron content of brain and liver in normal and hepato-lenticular degeneration

    Brain

    (1948)
  • J.N. Cumings

    Trace metals in the brain and Wilson's Disease

    J. Clin. Path.

    (1968)
  • G. Curzon et al.

    Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyin-doleacetic acid in small regions of rat brain

    Br. J. Pharmac.

    (1970)
  • P.R. Dallman

    Tissue effects of iron deficiency

  • P.R. Dallman et al.

    Distribution of cytochrome C and myoglobin in rats with dietary iron-deficiency

    Pediatrics

    (1965)
  • P.R. Dallman et al.

    Brain iron: persistent deficiency following short term iron deprivation in the young rat

    Br. J. Haemat.

    (1975)
  • R.A. Dietrich

    Tissue and subcellular distribution of mammalian aldehyde-oxidising capacity

    Biochem. Pharmac.

    (1966)
  • W.D. Denckla et al.

    The determination of tryptophan in plasma, liver and urine

    J. Lab. Clin. Med.

    (1967)
  • V.R. Edgerton et al.

    Iron deficiency anaemia and physical performance and activity of rats

    J. Nutr.

    (1972)
  • G.M. Everett et al.

    Pharmacologie studies of some non-hydrazine MAO inhibitors

    Ann. N.Y. Acad. Sci.

    (1963)
  • L. Garby

    Iron deficiency: definition and prevalence

  • J. Glover et al.

    Activity pattern of iron-deficient rats

    Br. Med. J.

    (1974)
  • D.G. Grahame-Smith

    Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and l-tryptophan

    J. Neurochem.

    (1971)
  • Cited by (88)

    • The roles of iron and HFE genotype in neurological diseases

      2020, Molecular Aspects of Medicine
      Citation Excerpt :

      Iron deficient microglia fail to respond to LPS stimulus and have decreased IL-1β expression (Rosato-Siri et al., 2018) and IL-1β has been previously shown to promote remyelination through the induction of IGF-1 (Mason et al., 2001) further tying the link between iron and myelination (Connor and Kettenmann, 2013). Beyond cell division, neurons need adequate and timely iron supply for dendritic arborization, synapse formation, and neurotransmitter synthesis (Youdim et al., 1980; Rudisill et al., 2019; Bastian et al., 2016). For example, tyrosine hydroxylase and tryptophan hydroxylase involved in synthesis of monoamines (dopamine and serotonin) use iron as a cofactor.

    • Iron and mechanisms of emotional behavior

      2014, Journal of Nutritional Biochemistry
      Citation Excerpt :

      A large body of evidence has indicated that impaired emotional behaviors are associated with iron deficiency through altered dopamine metabolism [14,20,74,75]. In general, there is a universal negative effect of iron deficiency on dopamine functions [11,76,77], which are specific to brain region and the stage of neural development. Dopamine receptor 1 (D1R) expression is down-regulated in the caudate putamen and prefrontal cortex of iron-deficient rats [78].

    • Waterborne manganese exposure alters plasma, brain, and liver metabolites accompanied by changes in stereotypic behaviors

      2012, Neurotoxicology and Teratology
      Citation Excerpt :

      Changes in these exploratory behaviors contradict typical nocturnal behavior (Scheer et al., 2003) and suggest that Mn-exposure may disrupt the circadian clock. Sleep disturbances are common among Parkinson's disease patients (Suzuki et al., 2011), and reversal of the circadian rhythm has been observed in iron deficient rats and is attributed to alterations in dopaminergic and/or noradrenergic activity (Youdim et al., 1980). In addition to dopamine and norepinephrine, circadian rhythm is largely influenced by serotonin, GABA, and glutamate in the suprachiasmatic nucleus (Wagner et al., 2001; Reghunandanan and Reghunandanan, 2006), and circadian fluctuations in dopamine, glutamate, and GABA have been reported in the striatum of rats (Castaneda et al., 2004).

    • Delayed alternation performance in rats following recovery from early iron deficiency

      2010, Physiology and Behavior
      Citation Excerpt :

      That is, the current protocol induced a significant level of ID (upwards of 40% brain iron loss) [4,9,12]. Thus, other dietary protocols that used different amounts of iron deficient ciao [1,2,14,15,19–21] may have resulted in a different pattern of behavioral findings. Finally, the findings of Lozoff and colleagues [27] showing long-term deficits in executive functions in adolescents who had been iron deficient as young children were collected in a population that experienced longer-term postnatal ID.

    View all citing articles on Scopus

    Present address: Israel Institute of Technology—Technion, School of Medicine, Department of Pharmacology, 12 Haaliya Street, Bat-Galim, POB 9649, Haifa. Israel.

    View full text